Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]

Authors

Publication Details

Journal
OncoTargets and Therapy
Published
2026-04-01
DOI
https://doi.org/10.2147/ott.s614697
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]

Zhiquan Tu, Tian Wang, Lian Zhang, Yaling Wang et al.
OncoTargets and Therapy
Nanoparticle-Based Drug Delivery
article

Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]

Zhiquan Tu, Tian Wang, Lian Zhang, Yaling Wang, Ping Yang, Qi Liu, Jing Wang, Feng Lin
article en

Abstract

No abstract available for this paper.
OncoTargets and TherapyVol. Volume 19
Openalex Percentile: Top 18%
Nanoparticle-Based Drug Delivery
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.